travoprost and Hair-Diseases

travoprost has been researched along with Hair-Diseases* in 2 studies

Other Studies

2 other study(ies) available for travoprost and Hair-Diseases

ArticleYear
Deepening of eyelid superior sulcus during topical travoprost treatment.
    Japanese journal of ophthalmology, 2009, Volume: 53, Issue:2

    Topical travoprost, a prostaglandin F(2alpha) (PGF(2alpha)) analog, has several well-known side effects, including a darkening of the eyelid and eyelash hypertrichosis, but there are no reports of a deepening of the eyelid superior sulcus associated with its use.. We examined one patient with unilateral normal-tension glaucoma and another with unilateral primary open-angle glaucoma, both of whom were treated with travoprost monotherapy unilaterally for 2 years.. Both patients gradually developed a deepening of the eyelid superior sulcus with hyperpigmentation in the eyelid skin of the treated eye. The disparity between the treated eye and the fellow eye was quite visible. However, the disparity returned to normal after discontinuation of travoprost for 15 months. A deepening of the eyelid superior sulcus is more significant in Asians, who seldom have an eyelid crease or deep sulcus. One proposed mechanism is a mechanical insult to the eyelid causing levator dehiscence. A second possible mechanism is fatty degeneration and reduced collagen fibers in the levator complex caused by the PGF(2alpha) analog. However, the exact mechanism remains to be determined.. A deepening of the eyelid superior sulcus should be considered a possible complication of topical travoprost that can be reversed by discontinuation of the medication.

    Topics: Aged; Antihypertensive Agents; Cloprostenol; Eyelashes; Eyelid Diseases; Female; Glaucoma, Open-Angle; Hair Diseases; Humans; Hyperpigmentation; Intraocular Pressure; Male; Travoprost

2009
Topical prostaglandin F(2alpha) analog induced poliosis.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    To report poliosis as a side effect associated with topical prostaglandin F(2alpha) (PGF(2alpha)) analogs.. Case series.. Seven patients treated with different topical PGF(2alpha) analogs for primary open angle glaucoma developed bilateral poliosis, either alone or in combination with other adverse effects of PGF(2alpha) analog therapy.. Poliosis is a possible adverse effect of topical PGF(2alpha) analog therapy which is previously unreported. Topical PGF(2alpha) analog therapy should be included in the differential diagnosis of patients with poliosis.

    Topics: Administration, Topical; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Eyelashes; Female; Glaucoma, Open-Angle; Hair Diseases; Humans; Hypertrichosis; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Pigmentation Disorders; Prostaglandins F, Synthetic; Travoprost

2004